Recent advances in neuroproteomics and potential application to studies of drug addiction

Neuropharmacology

Volumn 47, Issue SUPPL. 1, 2004, Pages 148-166

  Williams, Kenneth ^a   Wu, Terence ^a   Colangelo, Christopher ^a   Nairn, Angus C ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DIGE; Drug abuse; ICAT; Neurodegeneration; Protein array; Protein phosphorylation; Proteomics, Protein profiling; Schizophrenia

Indexed keywords

CANNABINOID; CYANAMIDE; HISTIDINE; HYDROGEN; LYSINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; NEUROTRANSMITTER RECEPTOR; NICOTINE; NITRIC OXIDE; OPIATE; PEPTIDE; PHOSPHOPROTEIN; PHOSPHOSERINE; PHOSPHOTHREONINE; POTASSIUM CHANNEL; PROTEIN G; PSYCHOSTIMULANT AGENT;

ACIDITY; AFFINITY CHROMATOGRAPHY; ALKALINITY; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; BRAIN MAPPING; BRAIN REGION; CARBONYLATION; CELL DIFFERENTIATION; CELL GROWTH; CELL TYPE; CHROMATOFOCUSING; COLON CANCER; DEGENERATIVE DISEASE; DEVELOPMENTAL STAGE; DISEASE COURSE; DNA MICROARRAY; DOWN REGULATION; DRUG DEPENDENCE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENTAL DISEASE; MICROINJECTION; MOLECULAR WEIGHT; NERVOUS SYSTEM; NONHUMAN; ONSET AGE; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; RNA ANALYSIS; STATISTICAL SIGNIFICANCE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; THALAMUS; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 4644315283     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.07.009     Document Type: Article

References (112)

1. Adam B.L., Qu Y., Davis J.W., Ward M.D., Clements M.A., Cazares L.H., Semmes O.J., Schellhammer P.F., Yasui Y., Feng Z., Wright G.L. Jr. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62:2002;3609-3614
2. Aebersold R. Constellations in a cellular universe. Nature. 422:2003a;115-116
3. Aebersold R. A mass spectrometric journey into protein and proteome research. J. Am. Soc. Mass Spectrom. 14:2003b;685-695
4. Anderson N.L., Anderson N.G. The human plasma proteome. Mol. Cell Proteomics. 1:2002;845-867
5. Becamel C., Alonso G., Galeotti N., Demey E., Jouin P., Ullmer C., Dumuis A., Bockaert J., Marin P. Synaptic multiprotein complexes associated with 5-HT2C receptors: a proteomic approach. EMBO J. 21:2002;2332-2342
6. Betgovargez E., Simonian M.H. Reproducibility and dynamic range characteristics of the proteome PF 2D system. Beckman Coulter Application Information Bulletin A-1964A. 2003
7. Blume-Jensen, P., Hunter, T., 2001. Oncogenic kinase signalling. Nature 411, 355-365.
8. Bibb J.A., Chen J., Taylor J.R., Svenningsson P., Nishi A., Snyder G.L., Yan Z., Sagawa Z.K., Ouimet C.C., Nairn A.C., Nestler E.J., Greengard P. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature. 410:2001;376-380
9. Boguski M.S., McIntosh M.W. Biomedical informatics for proteomics. Nature. 422:2003;233-237
10. Bonenfant D., Schmelzle T., Jacinto E., Crespo J.L., Mini T., Hall M.N., Jenoe P. Quantitation of changes in protein phosphorylation: a simple method based on stable isotope labeling and mass spectrometry. Proc. Natl. Acad. Sci. USA. 100:2003;880-885
11. Bushey M.M., Jorgenson J.W. Automated instrumentation for comprehensive two-dimensional high-performance liquid chromatography of proteins. Anal. Chem. 62:1990;161-167
12. Carlezon W.A. Jr., Nestler E.J. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci. 25:2002;610-615
13. Carrette O., Demalte I., Scherl A., Yalkinoglu O., Corthals G., Burkhard P., Hochstrasser D.F., Sanchez J.C. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics. 3:2003;1486-1494
14. Chong B.E., Yan F., Lubman D.M., Miller F.R. Chromatofocusing nonporous reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of proteins from human breast cancer whole cell lysates. Rapid Commun. Mass Spectrom. 15:2001;291-296
15. Choudhary J., Grant S.G. Proteomics in postgenomic neuroscience: the end of the beginning. Nat. Neurosci. 7:2004;440-445
16. Cohen P. The role of protein phosphorylation in neural and hormonal control of cellular activity. Nature. 296:1982;613-620
17. Cohen P. Signal integration at the level of protein kinases, protein phosphatases and their substrates. Trends Biochem. Sci. 17:1992;408-413
18. Engidawork E., Gulesserian T., Fountoulakis M., Lubec G. Aberrant protein expression in cerebral cortex of fetus with Down syndrome. Neuroscience. 122:2003;145-154
19. Ficarro S., McCleland M., Stukenberg P., Burke D., Ross M., Shabanowitz J., Hunt D., White F. Phosphproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 20:2002;301-305
20. Flora J., Muddiman D.C. Selective, sensitive, and rapid phosphopeptide identification in enzymatic digests using ESI-FTICR-MS with infrared multiphoton dissociation. Anal. Chem. 73:2001;3305-3311
21. Fountoulakis M., Juranville J.F., Dierssen M., Lubec G. Proteomic analysis of the fetal brain. Proteomics. 2:2002;1547-1576
22. Freeman W.M., Hemby S.E. Proteomics for protein expression profiling in neuroscience. Neurochem. Res. 29:2004;1065-1081
23. Gharbi S., Gaffney P., Yang A., Zvelebil M.J., Cramer R., Waterfield M.D., Timms J.F. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell Proteomics. 1:2002;91-98
24. Goshe M.B., Conrads T.P., Panisko E.A., Angell N.H., Veenstra T.D., Smith R.D. Phosphoprotein isotope-coded affinity tag approach for isolating and quantitating phosphopeptides in proteome-wide analyses. Anal. Chem. 73:2001;2578-2586
25. Goshe M.B., Veenstra T.D., Panisko E.A., Conrads T.P., Angell N.H., Smith R.D. Phosphoprotein isotope-coded affinity tags: application to the enrichment and identification of low-abundance phosphoproteins. Anal. Chem. 74:2002;607-616
26. Greenbaum D., Colangelo C., Williams K., Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 4:2003;117
27. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 19:1999a;1720-1730
28. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17:1999b;994-999
29. Gygi S.P., Corthals G.L., Zhang Y., Rochon Y., Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. USA. 97:2000;9390-9395
30. Haab B.B., Dunham M.J., Brown P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2:2001;1-13
31. Hakansson K., Cooper H.J., Emmett M.R., Costello C.E., Marshall A.G., Nilsson C.L. Electron capture dissociation and infrared multiphoton dissociation MS/MS of an N-glycosylated tryptic peptide to yield complementary sequence information. Anal. Chem. 73:2001;4530-4536
32. Han D.K., Eng J., Zhou H., Aebersold R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat. Biotechnol. 19:2001;946-951
33. Husi H., Grant S.G. Proteomics of the nervous system. Trends Neurosci. 24:2001;259-266
34. Husi H., Ward M.A., Choudhary J.S., Blackstock W.P., Grant S.G. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 3:2000;661-669
35. Issaq H.J., Veenstra T.D., Conrads T.P., Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292:2002;587-592
36. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3:2001;193-197
37. Jiang L., Lindpaintner K., Li H.F., Gu N.F., Langen H., He L., Fountoulakis M. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. Amino Acids. 25:2003;49-57
38. Jin K., Mao X.O., Cottrell B., Schilling B., Xie L., Row R.H., Sun Y., Peel A., Childs J., Gendeh G., Gibson B.W., Greenberg D.A. Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis. FASEB J. 18:2004;287-299
39. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol. Psychiatr. 5:2000;142-149
40. Kalkum M., Lyon G.J., Chait B.T. Detection of secreted peptides by using hypothesis-driven multistage mass spectrometry. Proc. Natl. Acad. Sci. USA. 100:2003;2795-2800
41. Khawaja X., Xu J., Liang J.J., Barrett J.E. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment. J. Neurosci. Res. 75:2004;451-460
42. Kim S.I., Voshol H., van Oostrum J., Hastings T.G., Cascio M., Glucksman M.J. Neuroproteomics: expression profiling of the brains's proteomes in health and disease. Neurochem. Res. 29:2004;1317-1331
43. Klose J., Nock C., Herrmann M., Stuhler K., Marcus K., Bluggel M., Krause E., Schalkwyk L.C., Rastan S., Brown S.D., Bussow K., Himmelbauer H., Lehrach H. Genetic analysis of the mouse brain proteome. Nat. Genet. 30:2002;385-393
44. Knight Z.A., Schilling B., Row R.H., Kenski D.M., Gibson B.W., Shokat K.M. Phosphospecific proteolysis for mapping sites of protein phosphorylation. Nat. Biotechnol. 21:2003;1047-1054
45. Leonoudakis D., Conti L.R., Anderson S., Radeke C.M., McGuire L.M., Adams M.E., Froehner S.C., Yates J.R., Vandenberg C.A. Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x) associated proteins. J. Biol. Chem. 279:2004;22331-22346
46. Leung A.K., Andersen J.S., Mann M., Lamond A.I. Bioinformatic analysis of the nucleolus. Biochem. J. 376:2003;553-569
47. Li K.W., Hornshaw M.P., Van Der Schors R.C., Watson R., Tate S., Casetta B., Jimenez C.R., Gouwenberg Y., Gundelfinger E.D., Smalla K.H., Smit A.B. Proteomic analysis of rat brain postsynaptic density. J. Biol. Chem. 279:2004;987-1002
48. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science. 289:2000;1760-1763
49. Madoz-Gúrpide J., Wang H., Misek D.E., Brichory F., Hanash S.M. Protein based microarrays: a tool for probing the proteome of cancer cells and tissues. Proteomics. 1:2001;1279-1287
50. Mann M., Jensen O.N. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21:2003;255-261
51. Marcotte E.R., Srivastava L.K., Quirion R. cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmacol. Ther. 100:2003;63-74
52. McClung C.A., Nestler E.J. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat. Neurosci. 6:2003;1208-1215
53. McLachlin D.T., Chait B.T. Analysis of phosphorylated proteins and peptides by mass spectrometry. Curr. Opin. Chem. Biol. 5:2001;591-602
54. McLachlin D.T., Chait B.T. Improved b-elimination-based affinity purification strategy for enrichment of phosphopeptides. Anal. Chem. 75:2003;6826-6836
55. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:2000;53-67
56. Missler M., Sudhof T.C. Neurexins: three genes and 1001 products. Trends Genet. 14:1998;20-26
57. Mootha V.K., Bunkenborg J., Olsen J.V., Hjerrild M., Wisniewski J.R., Stahl E., Bolouri M.S., Ray H.N., Sihag S., Kamal M., Patterson N., Lander E.S. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell. 115:2003;629-640
58. Mouledous L., Hunt S., Harcourt R., Harry J.L., Williams K.L., Gutstein H.B. Proteomic analysis of immunostained, laser_capture microdissected brain samples. Electrophoresis. 24:2003;296-302
59. Nestler E.J. Psychogenomics: opportunities for understanding addiction. J. Neurosci. 21:2001b;8324-8327
60. Nestler E.J., Barrot M., Self D.W. DeltaFosB: a sustained molecular switch for addiction. Proc. Natl. Acad. Sci. USA. 98:2001;11042
61. Nielsen U.B., Cardone M.H., Sinskey A.J., MacBeath G., Sorger P.K. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc. Natl. Acad. Sci. USA. 100:2003;9330-9335
62. Oda Y., Nagasu T., Chait B.T. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 19:2001;379-382
63. Olsen J.V., Andersen J.R., Nielsen P.A., Nielsen M.L., Figeys D., Mann M., Wisniewski J.R. HysTag - a novel proteomic quantification tool applied to differential display analysis of membrane proteins from distinct areas of mouse brain. Mol. Cell Proteomics. 3:2004;82-92
64. Opiteck G.J., Jorgenson J.W. Two-dimensional SEC/RPLC coupled to mass spectrometry for the analysis of peptides. Anal. Chem. 69:1997;2283-2291
65. Opiteck G.J., Ramirez S.M., Jorgenson J.W., Moseley M.A. Comprehensive two-dimensional high-performance liquid chromatography for the isolation of overexpressed proteins and proteome mapping. Anal. Biochem. 258:1998;349-361
66. Pasa-Tolic L., Lipton M.S., Masselon C.D., Anderson G.A., Shen Y., Tolic N., Smith R.D. Gene expression profiling using advanced mass spectrometric approaches. J. Mass Spectrom. 37:2002;1185-1198
67. Paulson L., Martin P., Nilsson C.L., Ljung E., Westman_Brinkmalm A., Blennow K., Davidsson P. Comparative proteome analysis of thalamus in MK-801-treated rats. Proteomics. 4:2004;819-825
68. Pawson T., Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science. 278:1997;2075-2080
69. Peng J., Kim M.J., Cheng D., Duong D.M., Gygi S.P., Sheng M. Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J. Biol. Chem. 279:2004;21003-21011
70. Perlson, E., Medzihradszky, K.F., Darula, Z., Munno, D.W., Syed, N.I., Burlingame, A.L., Fainzilber, M., 2004. Differential proteomics reveals multiple components in retrogradely transported axoplasm after nerve injury. Mol. Cell Proteomics 3, 510-520.
71. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., Mills G.B., Simone C., Fishman D.A., Kohn E.C., Liotta L.A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 359:2002;572-577
72. Prabakaran, S., Swatton, J.E., Ryan, M.M., Huffaker, S.J., Huang, J.J., Griffin, J.L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K.S., Karp, N.A., Hester, S., Tkachev, D., Mimmack, M.L., Yolken, R.H., Webster, M.J., Torrey, E.F., Bahn, S., 2004. Mitochondrial dysfunction in Schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry. 9, 684-697.
73. Qiu Y., Sousa E.A., Hewick R.M., Wang J.H. Acid-labile isotope-coded extractants: a class of reagents for quantitative mass spectrometric analysis of complex protein mixtures. Anal. Chem. 74:2002;4969-4979
74. Rappsilber J., Ryder U., Lamond A.I., Mann M. Large-scale proteomic analysis of the human spliceosome. Genome Res. 12:2002;1231-1245
75. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11:1999;1598-1604
76. Rockhill B. Proteomic patterns in serum and identification of ovarian cancer. Lancet. 360:2002;169-170
77. Rohlff C., Hollis K. Modern proteomic strategies in the study of complex neuropsychiatric disorders. Biol. Psychiatr. 53:2003;847-853
78. Rusnak F., Zhou J., Hathaway G.M. Identification of phosphorylated amd glycosylated sites in peptides by chemically targeted proteolysis. J. Biomol. Tech. 13:2002;228-237
79. Schonberger S.J., Edgar P.F., Kydd R., Faull R.L., Cooper G.J. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics. 1:2001;1519-1528
80. Shi Y., Xiang R., Crawford J.K., Colangelo C.M., Horváth C., Wilkins J.A. A simple solid phase mass tagging approach for quantitative proteomics. J. Proteome Res. 3:2004;104-111
81. Sokolov B.P., Polesskaya O.O., Uhl G.R. Mouse brain gene expression changes after acute and chronic amphetamine. J. Neurochem. 84:2003;244-252
82. Soreghan B.A., Yang F., Thomas S.N., Hsu J., Yang A.J. High-throughput proteomic-based identification of oxidatively induced protein carbonylation in mouse brain. Pharm. Res. 20:2003;1713-1720
83. Stears R.L., Martinsky T., Schena M. Trends in microarray analysis. Nat. Med. 9:2003;140-145
84. Steinberg T.H., Agnew B.J., Gee K.R., Leung W.Y., Goodman T., Schulenberg B., Hendrickson J., Beechem J.M., Haugland R.P., Patton W.F. Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology. Proteomics. 3:2003;1128-1144
85. Stevens S.M., Zharikova A.D., Prokai L. Proteomic analysis of the synaptic plasma membrane fraction isolated from rat forebrain. Brain Res. Mol. Brain Res. 117:2003;116-128
86. Stoeckli M., Chaurand P., Hallahan D.E., Caprioli R.M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat. Med. 7:2001;493-496
87. Svensson M., Skold K., Svenningsson P., Andren P.E. Peptidomics-based discovery of novel neuropeptides. J. Proteome Res. 2:2003;213-219
88. Swatton J.E., Prabakaran S., Karp N.A., Lilley K.S., Bahn S. Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis. Mol. Psychiatr. 9:2004;128-143
89. Tang W., Wesley M., Freeman W.M., Liang B., Hemby S.E. Alterations in ionotropic glutamate receptor subunits during binge cocaine self_administration and withdrawal in rats. J. Neurochem. 89:2004;1021-1033
90. Tonge R., Shaw J., Middleton B., Rowlinson R., Rayner S., Young J., Pognan F., Hawkins E., Currie I., Davison M. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics. 1:2001;377-396
91. Van den Bergh G., Clerens S., Vandesande F., Arckens L. Reversed-phase high-performance liquid chromatography prefractionation prior to two-dimensional difference gel electrophoresis and mass spectrometry identifies new differentially expressed proteins between striate cortex of kitten and adult cat. Electrophoresis. 24:2003;1471-1481
92. Voshol H., Glucksman M.J., van Oostrum J. Proteomics in the discovery of new therapeutic targets for psychiatric disease. Curr. Mol. Med. 3:2003;447-458
93. Walikonis R.S., Jensen O.N., Mann M., Provance D.W., Mercer J.A., Kennedy M.B. Identification of proteins in the postsynaptic density fraction by mass spectrometry. J. Neurosci. 20:2000;4069-4080
94. Wall D.B., Parus S.J., Lubman D.M. Three-dimensional protein map according to pI, hydrophobicity and molecular mass. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 774:2002;53-58
95. Wang H., Kachman M.T., Schwartz D.R., Cho K.R., Lubman D.M. A protein molecular weight map of ES2 clear cell ovarian carcinoma cells using a two-dimensional liquid separations/mass mapping technique. Electrophoresis. 23:2002;3168-3181
96. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19:2001;242-247
97. Washburn M., Koller A., Oshiro G., Ulaszek R., Plouffe D., Deciu C., Winzeler E., Yates J. Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 100:2003;3107-3112
98. Wolters D.A., Washburn M.P., Yates J.R. An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73:2001;5683-5690
99. Wu Q., Maniatis T. A striking organization of a large family of human neural cadherin_like cell adhesion genes. Cell. 97:1999;779-790
100. Wu B., Abbott T., Fishman D., McMurray W., Mor G., Stone K., Ward D., Williams K., Zhao H. Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. Bioinformatics. 19:2003a;1636-1643
101. Wu C.C., MacCoss M.J., Howell K.E., Yates J.R. A method for the comprehensive proteomic analysis of membrane proteins. Nat. Biotechnol. 21:2003b;532-538
102. Yao W.D., Gainetdinov R.R., Arbuckle M.I., Sotnikova T.D., Cyr M., Beaulieu J.M., Torres G.E., Grant S.G., Caron M.G. Identification of PSD-95 as a regulator of dopamine_mediated synaptic and behavioral plasticity. Neuron. 41:2004;625-638
103. Yan J.X., Devenish A.T., Wait R., Stone T., Lewis S., Fowler S. Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics. 2:2002;1682-1698
104. Yan F., Sreekumar A., Laxman B., Chinnaiyan A.M., Lubman D.M., Barder T.J. Protein microarrays using liquid phase fractionation of cell lysates. Proteomics. 3:2003a;1228-1235
105. Yan F., Subramanian B., Nakeff A., Barder T.J., Parus S.J., Lubman D.M. A comparison of drug-treated and untreated HCT-116 human colon adenocarcinoma cells using a 2-D liquid separation mapping method based upon chromatofocusing PI fractionation. Anal. Chem. 75:2003b;2299-2308
106. Yoshimura Y., Yamauchi Y., Shinkawa T., Taoka M., Donai H., Takahashi N., Isobe T., Yamauchi T. Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J. Neurochem. 88:2004;759-768
107. Yuferov V., Kroslak T., Laforge K.S., Zhar Y., Ho A., Kreek M.J. Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate microarray analysis. Synapse. 48:2003;157-169
108. Zabel C., Chamrad D.C., Priller J., Woodman B., Meyer H.E., Bates G.P., Klose J. Alterations in the mouse and human proteome caused by Huntington's disease. Mol. Cell Proteomics. 1:2002;366-375
109. Zhou H., Watts J.D., Aebersold R. A systematic approach to the analysis of protein phosphorylation. Nat. Biotechnol. 19:2001;375-378
110. Zhou G., Li H., DeCamp D., Chen S., Shu H., Gong Y., Flaig M., Gillespie J.W., Hu N., Taylor P.R., Emmert-Buck M.R., Liotta L.A., Petricoin E.F., Zhao Y. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell Proteomics. 1:2002a;117-124
111. Zhou H., Ranish J.A., Watts J.D., Aebersold R. Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry. Nat. Biotechnol. 20:2002b;512-515
112. Zhu H., Bilgin M., Bangham R., Hall D., Casamayor A., Bertone P., Lan N., Jansen R., Bidlingmaier S., Houfek T., Mitchell T., Miller P., Dean D.A., Gerstein M., Snyder M. Global analysis of protein activities using proteome chips. Science. 293:2001;2101-2105